Status:
TERMINATED
Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography
Lead Sponsor:
GE Healthcare
Collaborating Sponsors:
ABX CRO
Examination Management Services Inc.
Conditions:
Renal Insufficiency
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
It is well known that X-ray contrast media can affect kidney function in some patients, especially when administered intra-arterially, and patients who already suffer from reduced kidney function and ...
Detailed Description
GEHC has decided not to provide this detail
Eligibility Criteria
Inclusion
- Patients with a combination of diabetes mellitus (type I or II) and renal impairment who are referred for a contrast-enhanced CT examination.
Exclusion
- Concurrent administration of potentially nephroprotective or nephrotoxic drugs is not permitted.
- Patients undergoing dialysis or kidney transplantation will not be included.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
656 Patients enrolled
Trial Details
Trial ID
NCT00209417
Start Date
June 1 2005
End Date
July 1 2011
Last Update
October 17 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GE Healthcare
Princeton, New Jersey, United States, 08540
2
GE Healthcare
Amersham, United Kingdom, HP7 9LL